ZyVersa Therapeutics, Inc. (ZVSA): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$928.4K
As of 2021-12-31
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2021-12-31 | $928.4K | n/a | 2022-04-15, Balance as of period end |